𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cellular immunity in patients with malignant melanoma and their household contacts

✍ Scribed by L. E. Spitler; F. N. Littooy; R. W. Sagebiel

Publisher
Springer-Verlag
Year
1977
Tongue
English
Weight
719 KB
Volume
2
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effect of methanol extraction residu
The effect of methanol extraction residue of BCG on the cellular immune response in patients with malignant melanoma
✍ Bartal, Arie ;Cohen, Yoram ;Mekori, Tamar ;Haasz, Robert ;Robinson, E. πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 480 KB

Twenty-one patients with malignant melanoma stage III and IV were treated by intradermal injections of MER--methanol extraction residue of Baccillus Calmette-GuΓ©rin (BCG). Twelve of the patients, all with active disease, received chemotherapy in addition. Tests of skin reactivity to recall antigens

Immune responsiveness of patients with m
Immune responsiveness of patients with malignant melanoma and carcinoma of the breast
✍ Loren Humphrey; Om Singla Ms πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 498 KB

Lymphocyte blastogenesis (LB) with PHA, CON-A, PWM, V,, (homologous tumor extract) plus T/B ratio for pre-IT, post-IT (2 months), and 3, 6, 9, 12, 18, and 24 months prior to each V,, booster are reported. Pre-IT and post-IT LB-PHA were similar for Stage I (ST I) or Stage I1 (ST 11) breast cancer (BC

Estrogen receptors in patients with mali
Estrogen receptors in patients with malignant melanoma
✍ Edward T. Creagan; James N. Ingle; John E. Woods; Douglas J. Pritchard; Nai-Sian πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 213 KB πŸ‘ 2 views
Sequential studies on cell-mediated tumo
Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma
✍ I. HellstrΓΆm; G. A. Warner; K. E. HellstrΓΆm; H. O. SjΓΆgren πŸ“‚ Article πŸ“… 1973 πŸ› John Wiley and Sons 🌐 French βš– 920 KB

## Abstract Ten human patients with malignant melanoma were followed with respect to two __in vitro__ parameters of tumor immunity, the ability of the patients' blood lymphocytes to destroy cultivated melanoma cells, and the ability of the patients' sera to block such destruction, and with respect